Ribavirin News and Research

RSS
Ribavirin, also known as Copegus, Rebetol, Virazole, or a component of Rebetron, is a type of antiviral medicine called a nucleoside analogue. This medicine blocks the ability of the hepatitis C virus (HCV) to make more copies of itself. Ribavirin is not active against HIV. Ribavirin is used in combination with interferon alfa-2a or -2b or peginterferon alfa-2a or -2b to treat HIV infected patients who are also infected with HCV.
Potential compounds targeting SARS-COV-2 main protease (in vivo)

Potential compounds targeting SARS-COV-2 main protease (in vivo)

Researchers review the origins of SARS-CoV-2 and present treatment methods

Researchers review the origins of SARS-CoV-2 and present treatment methods

SARS-CoV-2 NSP14 induces potent inflammation via NF-κB pathways, finds study

SARS-CoV-2 NSP14 induces potent inflammation via NF-κB pathways, finds study

Could graphene oxide nanosheets be an effective SARS-CoV-2 antiviral in PPE?

Could graphene oxide nanosheets be an effective SARS-CoV-2 antiviral in PPE?

Natural products a rich source for novel antiviral compounds

Natural products a rich source for novel antiviral compounds

A machine learning approach to identify drugs that could be repurposed to fight COVID-19

A machine learning approach to identify drugs that could be repurposed to fight COVID-19

Remdesivir disrupts SARS-CoV-2 more effectively than other similar drugs

Remdesivir disrupts SARS-CoV-2 more effectively than other similar drugs

Researchers use AI platform to identify best combination of available therapies against COVID-19.

Researchers use AI platform to identify best combination of available therapies against COVID-19.

Using AI to find optimal combination of available therapies against SARS-CoV-2

Using AI to find optimal combination of available therapies against SARS-CoV-2

Nucleic acid-hydrolyzing scFv 3D8 exhibits potent antiviral effects on SARS-CoV-2

Nucleic acid-hydrolyzing scFv 3D8 exhibits potent antiviral effects on SARS-CoV-2

Rutgers leading a clinical trial assessing combination treatment for coronavirus

Rutgers leading a clinical trial assessing combination treatment for coronavirus

Resveratrol shows potential as SARS-CoV-2 antiviral, study finds

Resveratrol shows potential as SARS-CoV-2 antiviral, study finds

Genome-wide CRISPR screens reveal resistance and sensitization mechanisms of drugs used in COVID-19

Genome-wide CRISPR screens reveal resistance and sensitization mechanisms of drugs used in COVID-19

Evaluating the use of sofosbuvir and daclatasvir for treatment of COVID-19

Evaluating the use of sofosbuvir and daclatasvir for treatment of COVID-19

Targeting SARS-CoV-2 with off-the-shelf CAR-NK cells

Targeting SARS-CoV-2 with off-the-shelf CAR-NK cells

Dutch trial of convalescent plasma in COVID-19 discontinued

Dutch trial of convalescent plasma in COVID-19 discontinued

Does interferon therapy work in COVID-19?

Does interferon therapy work in COVID-19?

Potential targets discovered for COVID-19 therapy

Potential targets discovered for COVID-19 therapy

Antiviral cocktail may help treat mild COVID-19 patients

Antiviral cocktail may help treat mild COVID-19 patients

Experts advise not to make COVID-19 crisis worse by rushing for cures

Experts advise not to make COVID-19 crisis worse by rushing for cures